Value of ultrasound and magnetic resonance imaging combined with tumor markers in the diagnosis of ovarian tumors

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

WORD

HTML

804

Tables (1-5)

156

Sum=1016

Publishing Process of This Article

Item

Count

Browse

Download

212

Sum=287

Nov 6, 2023 (publication date) through Jul 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Nov 6, 2023; 11(31): 7553-7561
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7553

Table 3 Serum tumor markers in patients with benign and malignant tumors

CA125: Carbohydrate antigen 125; HE4: Human epididymis protein 4.

Citation: Yang Q, Zhang H, Ma PQ, Peng B, Yin GT, Zhang NN, Wang HB. Value of ultrasound and magnetic resonance imaging combined with tumor markers in the diagnosis of ovarian tumors. World J Clin Cases 2023; 11(31): 7553-7561
URL: https://www.wjgnet.com/2307-8960/full/v11/i31/7553.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i31.7553